Photo: CNBC
Business & Finance
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
TL;DR
- S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 9, 2026 · Updated 11/9/2026, 2:50:49 PM · Reported with: CNBC
Sources (1)
NRI Bytes writes its own articles from the reporting below.
CNBC — Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approvalUp next · Business & Finance
Eternal shares rebound over 70% from March lows, emerge as top Nifty 50 recovery stock; what drove the rally?
Read next →
More stories
Business & Finance
Your meal cost is set to rise: Eggs and chicken prices may rise 25-30% by December
46m ago
Business & Finance
Goodyear Tire CEO Mark Stewart steps down as company continues turnaround plan
46m ago
Business & Finance
E20 petrol row: Keralam steps up fuel checks after Karnataka flags ethanol blending above prescribed 20% limit
1h ago
Business & Finance
Is Wall Street Underpricing AI Now? Tech Stocks Look Cheap For First Time In 9 Years
1h ago
